SpringWorks Therapeutics Inc

SWTX

Equity

ISIN US85205L1070 / Valor 49628191

NASDAQ (2024-09-17)

USD 35.42-0.39%

SpringWorks Therapeutics Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

SpringWorks Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and delivery of precision medicine treatments for patients with devastating cancers. The company employs a meticulous approach to drug development, rigorously analyzing promising molecules to maximize their therapeutic potential. SpringWorks Therapeutics is known for its collaborative efforts, partnering with both industry and academic entities to enhance the chances of success in its endeavors. The organization is driven by a team with extensive experience in oncology drug development and commercialization, committed to advancing targeted oncology solutions. Central to its mission is a set of core values emphasizing relentless determination, rapid action, and a collaborative spirit without ego, all aimed at improving the lives of cancer patients. Through its dedication to innovation and a deep-seated care for patients, SpringWorks Therapeutics strives to address unmet medical needs by bringing novel treatments to the market with urgency and precision.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

34.5%1Y

-52.6%3Y

50.3%5Y

Performance

60.2%1Y

73.0%3Y

75.2%5Y

Volatility